Cmc Pharmaceuticals

Developing new and better drug formulations.

Based in OH

🤖

AI Overview

With $390K in lobbying spend across 12 quarterly filings, Cmc Pharmaceuticals is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2023 to 2025.

$390K
Total Spend
3
Years Active
1
Firms Hired
3
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$70K
2024$160K
2025$160K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Cmc Pharmaceuticals disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEDefense, Dept of (DOD)White House Office
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Defense, Government Issues

Support for DOD Chemical Biological Defense medical countermeasures pre and post-exposure protection policy.

Support for DOD Chemical Biological Defense medical countermeasures pre and post exposure protection funding.

Support for DOD Chemical Biological Defense medical countermeasures pre and post exposure protection policy.

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.